North Chelmsford, Mass.-based medical device startup EndoEvolution named a new chief executive as the company closed a $5 million funding round in support of new commercialization efforts.
Ron Rudowsky was appointed president & CEO of the automated suturing devices maker, taking the place of EndoEvolution founder Jerry Brecher, who will remain "closely involved" as the company heads to the market.
"We are extremely enthusiastic about our investment in EndoEvolution and we’re pleased to continue and increase our support for the company," lead Series C round investor Spring Bay’s managing director Dan Ryan said in prepared remarks. "EndoEvolution’s Endo360° Minimally Invasive suturing devices are in production and ready for market, and so we are extremely pleased that such an outstanding industry leader as Ron Rudowsky has come on board to lead the commercialization of EndoEvolution’s outstanding technology."
Rudowsky has spent more than 36 years in medtech, 30 of them in executive management positions, according to a press release.
